Since releasing on 25th May 2021, Biomutant has gone on to sell over one million copies worldwide across PlayStation 4, Xbox One, and PC platforms. The Embracer Group confirmed the news as part of its Q1 2021 financial results, where it was also stated that publisher THQ Nordic recouped all of its costs on the project within the first week of availability. That includes funds for the development of the game itself as well as purchasing developer Experiment 101 along with the Biomutant IP.
The report said: "The main revenue driver in the quarter was the release of Biomutant from our internal studio Experiment 101. So far, the game has sold more than one million copies. The full investment into development and marketing as well as the acquisition cost for Experiment 101 and the IP, was recouped within a week after launch.”
Biomutant was subject to a very mixed reception when it launched after years of development time and anticipation, with criticism for its overly ambitious mechanics and dull combat and open world some of the biggest talking points. In the 4/10 Push Square review, we concluded: "By trying to do so much, Biomutant skipped the part where it built a solid basis to work from. While there's still potential here, Experiment 101's first attempt hasn't realised it." The game still has its supporters, however.